Literature DB >> 19426136

Glycosylation- and phosphorylation-dependent intracellular transport of lysosomal hydrolases.

Sandra Pohl1, Katrin Marschner, Stephan Storch, Thomas Braulke.   

Abstract

Lysosomes contain more than 50 soluble hydrolases that are targeted to lysosomes in a mannose 6-phosphate (Man6P)-dependent manner. The phosphorylation of man- nose residues on high mannose-type oligosaccharides of newly synthesized lysosomal enzymes is catalyzed by two multimeric enzymes, GlcNAc-1-phosphotransferase and GlcNAc-1-phosphodiester-alpha-N-acetylglucosaminidase, allowing the binding to two distinct Man6P receptors in the Golgi apparatus. Inherited defects in the GlcNAc-1-phosphotransferase complex result in missorting and cellular loss of lysosomal enzymes, and the subsequent lysosomal dysfunction causes the lysosomal storage disorders mucolipidosis types II and III. Biosynthetic studies and the availability of Man6P receptor-deficient mouse models have provided new insights into the structural requirements for preferential binding of subsets of lysosomal enzymes to Man6P receptors as well as the identification of alternative targeting pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19426136     DOI: 10.1515/BC.2009.076

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  19 in total

1.  A novel single-chain antibody fragment for detection of mannose 6-phosphate-containing proteins: application in mucolipidosis type II patients and mice.

Authors:  Sven Müller-Loennies; Giovanna Galliciotti; Katrin Kollmann; Markus Glatzel; Thomas Braulke
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

Review 2.  Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy.

Authors:  Ricardo J Solá; Kai Griebenow
Journal:  BioDrugs       Date:  2010-02-01       Impact factor: 5.807

3.  Site-1 protease-activated formation of lysosomal targeting motifs is independent of the lipogenic transcription control.

Authors:  Sarah Klünder; Jörg Heeren; Sandra Markmann; René Santer; Thomas Braulke; Sandra Pohl
Journal:  J Lipid Res       Date:  2015-06-24       Impact factor: 5.922

4.  Enzyme replacement therapy for Morquio A: an active recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Escherichia coli BL21.

Authors:  Alexander Rodríguez; Angela J Espejo; Alejandra Hernández; Olga L Velásquez; Lina M Lizaraso; Henry A Cordoba; Oscar F Sánchez; Carlos J Alméciga-Díaz; Luis A Barrera
Journal:  J Ind Microbiol Biotechnol       Date:  2010-06-27       Impact factor: 3.346

5.  Mannose 6 dephosphorylation of lysosomal proteins mediated by acid phosphatases Acp2 and Acp5.

Authors:  Georgia Makrypidi; Markus Damme; Sven Müller-Loennies; Maria Trusch; Bernhard Schmidt; Hartmut Schlüter; Joerg Heeren; Torben Lübke; Paul Saftig; Thomas Braulke
Journal:  Mol Cell Biol       Date:  2011-12-12       Impact factor: 4.272

6.  Transport of arylsulfatase A across the blood-brain barrier in vitro.

Authors:  Frank Matthes; Philipp Wölte; Annika Böckenhoff; Sabine Hüwel; Mareike Schulz; Pia Hyden; Jens Fogh; Volkmar Gieselmann; Hans-Joachim Galla; Ulrich Matzner
Journal:  J Biol Chem       Date:  2011-03-28       Impact factor: 5.157

Review 7.  Disulfide reduction in the endocytic pathway: immunological functions of gamma-interferon-inducible lysosomal thiol reductase.

Authors:  Karen Taraszka Hastings; Peter Cresswell
Journal:  Antioxid Redox Signal       Date:  2011-04-20       Impact factor: 8.401

8.  A bacterial glycosidase enables mannose-6-phosphate modification and improved cellular uptake of yeast-produced recombinant human lysosomal enzymes.

Authors:  Petra Tiels; Ekaterina Baranova; Kathleen Piens; Charlotte De Visscher; Gwenda Pynaert; Wim Nerinckx; Jan Stout; Franck Fudalej; Paco Hulpiau; Simon Tännler; Steven Geysens; Annelies Van Hecke; Albena Valevska; Wouter Vervecken; Han Remaut; Nico Callewaert
Journal:  Nat Biotechnol       Date:  2012-11-18       Impact factor: 54.908

9.  Lysosomal Proteome and Secretome Analysis Identifies Missorted Enzymes and Their Nondegraded Substrates in Mucolipidosis III Mouse Cells.

Authors:  Giorgia Di Lorenzo; Renata Voltolini Velho; Dominic Winter; Melanie Thelen; Shiva Ahmadi; Michaela Schweizer; Raffaella De Pace; Kerstin Cornils; Timur Alexander Yorgan; Saskia Grüb; Irm Hermans-Borgmeyer; Thorsten Schinke; Sven Müller-Loennies; Thomas Braulke; Sandra Pohl
Journal:  Mol Cell Proteomics       Date:  2018-05-17       Impact factor: 5.911

10.  A case of mucolipidosis II presenting with prenatal skeletal dysplasia and severe secondary hyperparathyroidism at birth.

Authors:  Ju Sun Heo; Ka Young Choi; Se Hyoung Sohn; Curie Kim; Yoon Joo Kim; Seung Han Shin; Jae Myung Lee; Juyoung Lee; Jin A Sohn; Byung Chan Lim; Jin A Lee; Chang Won Choi; Ee-Kyung Kim; Han-Suk Kim; Beyong Il Kim; Jung-Hwan Choi
Journal:  Korean J Pediatr       Date:  2012-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.